Well-Tempered Meta-dynamics for PPARγ Agonist Classification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods, such as conventional molecular dynamics simulation, struggle to distinguish between peroxisome proliferator-activated receptor γ (PPARγ) full agonists, partial agonists, and antagonists due to limited sampling efficiency and inability to cross higher free energy barriers, leading to inefficient prediction of compound activities, especially for compounds with diverse structures.
Innovation Solution
The use of Well-Tempered Meta-dynamic molecular dynamics simulation to obtain free energy surfaces of PPARγ binding with full agonists, partial agonists, and antagonists, allowing for qualitative differentiation of PPARγ activity by identifying distinct conformational states, thereby reducing the need for extensive laboratory testing and resources.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional molecular dynamics simulation is used to simulate PPARγ conformational changes, then the simulation can be performed with standard computational resources, but the sampling efficiency is limited and cannot cross higher free energy barriers, making it difficult to distinguish between full agonists, partial agonists, and antagonists
Solution Approach 1:
The patent applies Well-Tempered Meta-dynamics simulation which modifies the potential energy surface by introducing a time-dependent bias potential that gradually lowers free energy barriers. This parameter change in the simulation methodology enables the system to cross higher free energy barriers and sample rare conformational transitions that conventional molecular dynamics cannot achieve, thereby improving the ability to distinguish between full agonists, partial agonists, and antagonists
Solution Approach 2:
The patent employs dynamic simulation approaches where the simulation parameters themselves evolve over time. The Well-Tempered Meta-dynamics method dynamically adjusts the bias potential strength during the simulation, allowing the system to progressively explore higher energy states and transition between conformational states that would be inaccessible in static or conventional dynamic simulations
2Productivity
If conventional QSAR prediction method is used, then the prediction can be applied to compounds with similar structures, but it cannot distinguish whether an unknown compound belongs to full agonist, partial agonist or antagonist, and prediction efficiency significantly declines when the number of compounds increases
Solution Approach 1:
The patent performs preliminary molecular dynamics simulations to generate conformational ensembles and calculate binding free energies for representative compounds before building the QSAR model. This preliminary action provides accurate reference data for training the QSAR model, enabling it to distinguish between full agonists, partial agonists, and antagonists with high precision when screening large numbers of compounds
Solution Approach 2:
The patent introduces binding free energy calculations and conformational analysis as intermediary steps between the compound structure and the final activity prediction. These intermediaries provide mechanistic insights into how compounds bind to PPARγ and induce conformational changes, enabling the QSAR model to accurately predict not just activity but also the type of activity (full agonist, partial agonist, or antagonist)
3Loss of time
If simulation time of tens or hundreds of nanoseconds is used in conventional molecular dynamics, then the computational cost remains manageable, but the sampling efficiency is still insufficient to find the real stable structure of PPARγ
Solution Approach 1:
The patent modifies the simulation parameters by implementing Well-Tempered Meta-dynamics which introduces a time-dependent bias potential that accelerates sampling of rare events. This parameter change allows the simulation to effectively explore the conformational landscape and find stable structures in feasible simulation times, overcoming the limitation of conventional molecular dynamics where tens or hundreds of nanoseconds are insufficient
Data Source
AI summary
The present invention discloses a method of constructing a pharmacophore to determine whether a molecule is a peroxisome proliferator-activated receptor γ full agonist, partial agonist or antagonist in terms of a binding energy or a free energy surface comprising: providing a protein receptor mimicking said peroxisome proliferator-activated receptor γ and a corresponding ligand; docking the corresponding ligand and the protein receptor to form a docked conformation; performing at least two rounds of molecular dynamic simulation to obtain at least one trajectory and at least one free energy surface; inputting the trajectory to construct at least one pharmacophore and obtaining the binding energy of the corresponding ligand; comparing the molecule with the corresponding ligand in terms of the binding energy thereof to the protein receptor in order to determine whether the molecule is the peroxisome proliferator-activated receptor γ full agonist, partial agonist or antagonist.